ATE175347T1 - Verwendung eines serotoninagonisten in kombination mit einem tachykininrezeptorantagonisten zur herstellung eines arzneimittels zur prävention oder behandlung der migräne - Google Patents

Verwendung eines serotoninagonisten in kombination mit einem tachykininrezeptorantagonisten zur herstellung eines arzneimittels zur prävention oder behandlung der migräne

Info

Publication number
ATE175347T1
ATE175347T1 AT95307000T AT95307000T ATE175347T1 AT E175347 T1 ATE175347 T1 AT E175347T1 AT 95307000 T AT95307000 T AT 95307000T AT 95307000 T AT95307000 T AT 95307000T AT E175347 T1 ATE175347 T1 AT E175347T1
Authority
AT
Austria
Prior art keywords
prevention
treatment
combination
receptor antagonist
tachykine
Prior art date
Application number
AT95307000T
Other languages
English (en)
Inventor
Marlene Lois Cohen
Kirk Willis Johnson
Lee Alan Phebus
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE175347T1 publication Critical patent/ATE175347T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT95307000T 1994-10-05 1995-10-03 Verwendung eines serotoninagonisten in kombination mit einem tachykininrezeptorantagonisten zur herstellung eines arzneimittels zur prävention oder behandlung der migräne ATE175347T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/318,391 US5744482A (en) 1994-10-05 1994-10-05 Serotonin agonist in combination with a tachykinin receptor antagonist in the treatment or prevention of migraine

Publications (1)

Publication Number Publication Date
ATE175347T1 true ATE175347T1 (de) 1999-01-15

Family

ID=23237987

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95307000T ATE175347T1 (de) 1994-10-05 1995-10-03 Verwendung eines serotoninagonisten in kombination mit einem tachykininrezeptorantagonisten zur herstellung eines arzneimittels zur prävention oder behandlung der migräne

Country Status (12)

Country Link
US (1) US5744482A (de)
EP (1) EP0710479B1 (de)
AT (1) ATE175347T1 (de)
AU (1) AU4130196A (de)
DE (1) DE69507112T2 (de)
DK (1) DK0710479T3 (de)
ES (1) ES2125567T3 (de)
GR (1) GR3029666T3 (de)
IL (1) IL115451A0 (de)
SI (1) SI0710479T1 (de)
WO (1) WO1996011000A1 (de)
ZA (1) ZA958173B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020028798A1 (en) * 1995-12-12 2002-03-07 Omeros Medical Systems Irrigation solution and method for inhibition of pain and inflammation
US6492332B1 (en) 1995-12-12 2002-12-10 Omeros Corporation Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation
JPH10510540A (ja) 1994-12-12 1998-10-13 オメロス メディカル システムズ，インコーポレーテッド 灌注用溶液並びに疼痛、炎症及びけいれんの抑制法
US20040127884A1 (en) * 1994-12-12 2004-07-01 Omeros Corporation Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis
US7091181B2 (en) 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
WO1996019233A2 (en) * 1994-12-12 1996-06-27 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm
WO1996041633A1 (en) * 1995-06-08 1996-12-27 Eli Lilly And Company Methods of treating cold and allergic rhinitis
US6413961B1 (en) * 1995-12-12 2002-07-02 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain and inflammation
AU4074897A (en) * 1996-09-18 1998-04-14 Eli Lilly And Company A method for the prevention of migraine
GB9620777D0 (en) * 1996-10-07 1996-11-20 Merck Sharp & Dohme Therapeutic use
GB9816556D0 (en) * 1998-07-30 1998-09-30 Pfizer Ltd Therapy
DE19917347A1 (de) * 1999-04-16 2000-11-09 Gsf Forschungszentrum Umwelt Verfahren und Vorrichtung zum trockenen Anbringen von Substanzen an inhalierbare pulverförmige Trägerstoffe
JP2001172178A (ja) * 1999-10-25 2001-06-26 Pfizer Prod Inc 偏頭痛治療用のｎｋ−１レセプターアンタゴニスト及びエレトリプタン
AUPQ514600A0 (en) * 2000-01-18 2000-02-10 James Cook University Brain injury treatment
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
EP1465869B1 (de) 2001-12-21 2013-05-15 Exelixis Patent Company LLC Modulatoren von lxr
US20080213363A1 (en) * 2003-01-23 2008-09-04 Singh Nikhilesh N Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
US20070065463A1 (en) 2003-06-20 2007-03-22 Ronald Aung-Din Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions
US20050282879A1 (en) * 2004-06-17 2005-12-22 Foad Salehani Methods and composition for treatment of migraine and symptoms thereof
WO2007070504A2 (en) * 2005-12-13 2007-06-21 Morton Grove Pharmaceuticals, Inc. Stable and palatable oral liquid sumatriptan compositions
EP2185181A2 (de) * 2007-09-11 2010-05-19 Mondobiotech Laboratories AG Therapeutische verwendung von gastrin-1 und g-pen-grgdspca

Also Published As

Publication number Publication date
IL115451A0 (en) 1995-09-28
ZA958173B (en) 1997-04-01
DE69507112D1 (de) 1999-02-18
DE69507112T2 (de) 1999-06-10
US5744482A (en) 1998-04-28
AU4130196A (en) 1996-05-02
WO1996011000A1 (en) 1996-04-18
EP0710479B1 (de) 1999-01-07
GR3029666T3 (en) 1999-06-30
EP0710479A1 (de) 1996-05-08
ES2125567T3 (es) 1999-03-01
DK0710479T3 (da) 1999-08-30
SI0710479T1 (en) 1999-06-30

Similar Documents

Publication Publication Date Title
ATE175347T1 (de) Verwendung eines serotoninagonisten in kombination mit einem tachykininrezeptorantagonisten zur herstellung eines arzneimittels zur prävention oder behandlung der migräne
RU95106649A (ru) Производные бензимидазола в качестве непептидильных антагонистов рецепторов тахикинина, способ получения, фармацевтическая композиция
DE69533112T2 (de) Verwendung von flavolignanen zur herstellung von medikamenten mit antiproliferativer aktivität in gebärmutter,brust,eierstöcken
BG105534A (en) 5ht1 means and method for the treatment of migraine
PL398445A1 (pl) Kompozycje farmaceutyczne zawierające dekstrometorfan i chininę do leczenia zaburzeń neurologicznych
ATE292982T1 (de) Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu- opioidanagonisten und eines kappa - 2- opioidanagonisten
Hovell Comparison of buprenorphine, pethidine and pentazocine for the relief of pain after operation
ATE140388T1 (de) Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen
ATE398618T1 (de) Pharmazeutische zusammensetzungen zur behandlung von zns und anderen krankheiten
De la Garza et al. Effects of haloperidol and physostigmine on self-administration of local anesthetics
EA200300183A1 (ru) Новое сочетание агониста (5-th2) и антагониста (5-ht6) серотонина в качестве фармацевтической композиции
Jain et al. Analgesic efficacy of low-dose intrathecal neostigmine in combination with fentanyl and bupivacaine for total knee replacement surgery
Chen et al. Naloxone prolongs cutaneous nociceptive block by lidocaine in rats
Okutomi et al. Prophylactic epidural naloxone reduces the incidence and severity of neuraxial fentanyl-induced pruritus during labour analgesia in primiparous parturients
EP0799618A3 (de) Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs
EE03205B1 (et) Ropivakaiini kasutamine valuvaigistina kasutatava ravimpreparaadi valmistamiseks
DE69124380D1 (de) Verfahren und zusammensetzungen für die behandlung durch t-zellen vermittelter krankheiten
TW429262B (en) C5a receptor antagonists having substantially no agonist activity
ATE247965T1 (de) Paracetamol und buspiron enthaltende pharmazeutische zusammensetzung mit analgetischer wirkung
Abboud et al. Efficacy and safety of butorphanol nasal spray for the relief of postepisiotomy pain
Bessette et al. Fluoxetine and organic mood syndrome.
Yoo et al. Evaluation of palonosetron for the prevention of pain on injection of LCT/MCT propofol: Randomized controlled comparison with lidocaine
DE69923698D1 (de) Verwendung von 3-(1h-imidazol-4-ylmethyl)-indan-5-ol zur herstellung eines medikamentes zur intraspinalen, intrathekalen und epiduralen anwendung
Sebban et al. Dexfenfluramine profile in quantitative EEG and its topographical aspects
Locatelli et al. Naloxone: intravenously, intramuscular, inhalatory and intranasal use in emergency cases

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee